Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.0473 per EA under NDC 69315018210. Its NADAC has been published 256 times since Sep 29, 2021.
FDA first approved this application on Apr 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315018210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212798FDA Approved
4/6/2020
TE Code
AB
On Market Since
11/1/2019
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 256 times since Sep 29, 2021, and over the history we have for it it has declined 37.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.0786 (Apr 13, 2022) |
| All-time low | $0.0448 (Nov 20, 2024) |
| 52-week high | $0.0498 |
| 52-week low | $0.0455 |
| Median price | $0.0592 |
| Average price | $0.0589 |
| Largest weekly change | -28.1% (Apr 17, 2024) |
| Weeks tracked | 256 |
| Tracking since | Sep 29, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Leading Pharma, LLC, is $0.0473 per EA (NDC 69315018210), effective Aug 19, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 37.9%. It has been tracked across 256 weekly CMS publications since Sep 29, 2021.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Sep 29, 2021, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0448 (Nov 20, 2024) to a high of $0.0786 (Apr 13, 2022), with a median of $0.0592 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXYBUTYNIN 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 69315018210) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.